Imatge avançada en malalties neuroimmunològiques (ImaginEM)
                
            Publicacions destacades
- 
                                Clinical characterisation of patients in the post-acute stage of anti-NMDA receptor encephalitis: a prospective cohort study and comparison with patients with schizophrenia spectrum disordersGuasp, Mar; Rosa-Justicia, Mireia; Munoz-Lopetegi, Amaia; Martinez-Hernandez, Eugenia; Armangue, Thais;(...)Sanchez-Valle, Raquel; Santamaria, Joan; Compte, Albert; Castro-Fornielest, Josefina; Dalmau, Josep.Referència:Lancet Neurology 2022. 
- 
                                Dynamics and Predictors of Cognitive Impairment along the Disease Course in Multiple SclerosisLopez-Soley, Elisabet; Martinez-Heras, Eloy; Andorra, Magi; Solanes, Aleix; Radua, Joaquim;(...)Martinez-Lapiscina, Elena H; Villoslada, Pablo; Saiz, Albert; Solana, Elisabeth; Llufriu, Sara.Referència:J Pers Med 2021. 
- 
                                Oligoclonal IgM bands in the cerebrospinal fluid of patients with relapsing MS to inform long-term MS disabilityCapuano, Rocco; Zubizarreta, Irati; Alba-Arbalat, Salut; Sepulveda, Maria; Sola-Valls, Nuria;(...)Villoslada, Pablo; Saiz, Albert; Llufriu, Sara; Villar, Luisa M; Martinez-Lapiscina, Elena H.Referència:Multiple Sclerosis Journal 2021. 
- 
                                Regional grey matter microstructural changes and volume loss according to disease duration in multiple sclerosis patientsSolana, Elisabeth; Martinez-Heras, Eloy; Montal, Victor; Vilaplana, Eduard; Lopez-Soley, Elisabet;(...)Martinez-Lapiscina, E H; Prados, Ferran; Saiz, Albert; Fortea, Juan; Llufriu, Sara.Referència:Scientific Reports 2021. 
- 
                                Incidence and Impact of COVID-19 in MS: A Survey From a Barcelona MS UnitSepulveda, Maria; Llufriu, Sara; Martinez-Hernandez, Eugenia; Catala, Marti; Artola, Montse;(...)Aldea, Marta; Prats, Clara; Graus, Francesc; Blanco, Yolanda; Saiz, Albert.Referència:Neurology-Neuroimmunology & Neuroinflammation 2021. 
- 
                                Retinal and brain damage during multiple sclerosis course: inflammatory activity is a key factor in the first 5 yearsPulido-Valdeolivas, Irene; Andorra, Magi; Gomez-Andres, David; Nakamura, Kunio; Alba-Arbalat, Salut;(...)Camos-Carreras, Anna; Sanchez-Dalmau, Bernardo; Villoslada, Pablo; Saiz, Albert; Martinez-Lapiscina, Elena H.Referència:Scientific Reports 2020. 
- 
                                Characterization of multiple sclerosis lesions with distinct clinical correlates through quantitative diffusion MRIMartinez-Heras, Eloy; Solana, Elisabeth; Prados, Ferran; Andorra, Magi; Solanes, Aleix;(...)Sepulveda, Maria; Blanco, Yolanda; Saiz, Albert; Radua, Joaquim; Llufriu, Sara.Referència:Neuroimage-Clinical 2020. 
- 
                                Late-onset neuromyelitis optica spectrum disorder: The importance of autoantibody serostatusSepulveda, M; Delgado-García, G; Blanco, Y; Sola-Valls, N; Martinez-Lapiscina, EH;(...)Llufriu, S; Dalmau, J; Graus, F; Saiz, A; Ruiz-García, R.Referència:Neurology-Neuroimmunology & Neuroinflammation 2019. 
- 
                                Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trialZubizarreta, Irati; Florez-Grau, Georgina; Vila, Gemma; Cabezon, Raquel; Espana, Carolina;(...)Lozano, Miquel; Blanco, Yolanda; Steinman, Lawrence; Benitez-Ribas, Daniel; Villoslada, Pablo.Referència:Proceedings Of The National Academy Of Sciences Of The United States Of America 2019. 
- 
                                Assessing Biological and Methodological Aspects of Brain Volume Loss in Multiple Sclerosis.Andorra, Magi; Nakamura, Kunio; Lampert, Erika J; Pulido-Valdeolivas, Irene; Zubizarreta, Irati;(...)Tercero-Uribe, Ana; Blanco, Yolanda; Saiz, Albert; Villoslada, Pablo; Martinez-Lapiscina, Elena H.Referència:Jama Neurology 2018. 
